hydromorphinol
- CAS No.
- 2183-56-4
- Chemical Name:
- hydromorphinol
- Synonyms
- Oxymorphol;a-Oxymorphol;6a-Oxymorphol;6α-Oxymorphol;hydromorphinol;6-Oxymorphol (CRM);6α-Oxymorphol (CRM);14-Hydroxydihydromorphine;AABLHGPVOULICI-BRJGLHKUSA-N;6-Alpha-Hydroxy OxyMorphone
- CBNumber:
- CB0933076
- Molecular Formula:
- C17H21NO4
- Molecular Weight:
- 303.36
- MDL Number:
- MOL File:
- 2183-56-4.mol
- MSDS File:
- SDS
| Melting point | 252-253 °C(Solv: ethyl acetate (141-78-6)) |
|---|---|
| Boiling point | 517.6±50.0 °C(Predicted) |
| Density | 1.50±0.1 g/cm3(Predicted) |
| solubility | DMF: 20 mg/ml; DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml; DMSO: 10 mg/ml |
| form | A neat solid |
| pka | 9.39±0.60(Predicted) |
| FDA UNII | 1O00P9X5C1 |
hydromorphinol price More Price(7)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 21542 | 6α-Oxymorphol ≥98% | 2183-56-4 | 1mg | $129 | 2026-04-30 | Buy |
| Cayman Chemical | 25940 | 6α-Oxymorphol (CRM) | 2183-56-4 | 1mg | $264 | 2026-04-30 | Buy |
| Cayman Chemical | 21542 | 6α-Oxymorphol ≥98% | 2183-56-4 | 5mg | $516 | 2026-04-30 | Buy |
| Usbiological | 439186 | 6α-Oxymorphol | 2183-56-4 | 1mg | $523 | 2026-06-03 | Buy |
| Usbiological | 439186 | 6α-Oxymorphol | 2183-56-4 | 2mg | $779 | 2026-06-03 | Buy |
hydromorphinol Chemical Properties,Uses,Production
Description
6α-Oxymorphol (CRM) (Item No. 25940) is a certified reference material categorized as an opioid. It is a metabolite of oxymorphone (Item Nos. 15911 | ISO60171). 6α-Oxymorphol is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.
Uses
A metabolite of Oxymorphone
brand name
Ifex (Bristol-Myers Squibb).
References
[1] RICHARD D.S. CARLISS . Receptor reserve reflects differential intrinsic efficacy associated with opioid diastereomers[J]. Pharmacology Biochemistry and Behavior, 2009, 92 3: Pages 495-502. DOI: 10.1016/j.pbb.2009.01.019
[2] BOJAN LALOVIC PHD Evan K M, PHD. Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites[J]. Clinical Pharmacology & Therapeutics, 2006, 79 5: 461-479. DOI: 10.1016/j.clpt.2006.01.009
